Aurelie Tran-Barrail

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

HIV persistence in tissues on dolutegravir-based therapy is not associated with resistance mutations to dolutegravir.

HIV persistence in tissues on dolutegravir-based therapy is not associated with resistance mutations to dolutegravir.

Journal: Communications medicine

Published: September 17, 2025

Population pharmacokinetics of mycophenolic acid and Bayesian estimator in lung transplant adults recipients in the early post-transplant period.

Population pharmacokinetics of mycophenolic acid and Bayesian estimator in lung transplant adults recipients in the early post-transplant period.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: March 24, 2025

Pharmacokinetics of rifampicin and isoniazid in patients with HIV-tuberculosis coinfection receiving efavirenz-based antiretroviral treatment: an ANRS12292-RIFAVIRENZ sub-study.

Pharmacokinetics of rifampicin and isoniazid in patients with HIV-tuberculosis coinfection receiving efavirenz-based antiretroviral treatment: an ANRS12292-RIFAVIRENZ sub-study.

Journal: The Journal of antimicrobial chemotherapy

Published: December 06, 2024

Whole-body distribution of tenofovir, emtricitabine and dolutegravir in non-human primates.

Whole-body distribution of tenofovir, emtricitabine and dolutegravir in non-human primates.

Journal: The Journal of antimicrobial chemotherapy

Published: November 23, 2023

Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records.

Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records.

Journal: Antimicrobial agents and chemotherapy

Published: April 26, 2023

Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells.

Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells.

Journal: Nature communications

Published: April 04, 2023

Pharmacological Validation of Long-Term Treatment with Antiretroviral Drugs in a Model of SIV-Infected Non-Human Primates.

Pharmacological Validation of Long-Term Treatment with Antiretroviral Drugs in a Model of SIV-Infected Non-Human Primates.

Journal: Pharmaceutics

Published: September 23, 2022

Prolonged Antiretroviral Treatment Induces Adipose Tissue Remodelling Associated with Mild Inflammation in SIV-Infected Macaques.

Prolonged Antiretroviral Treatment Induces Adipose Tissue Remodelling Associated with Mild Inflammation in SIV-Infected Macaques.

Journal: Cells

Published: August 24, 2022

Inhibition of Adipose Tissue Beiging by HIV Integrase Inhibitors, Dolutegravir and Bictegravir, Is Associated with Adipocyte Hypertrophy, Hypoxia, Elevated Fibrosis, and Insulin Resistance in Simian Adipose Tissue and Human Adipocytes.

Inhibition of Adipose Tissue Beiging by HIV Integrase Inhibitors, Dolutegravir and Bictegravir, Is Associated with Adipocyte Hypertrophy, Hypoxia, Elevated Fibrosis, and Insulin Resistance in Simian Adipose Tissue and Human Adipocytes.

Journal: Cells

Published: April 28, 2022

Pharmacokinetics and tissue distribution of tenofovir, emtricitabine and dolutegravir in mice.

Pharmacokinetics and tissue distribution of tenofovir, emtricitabine and dolutegravir in mice.

Journal: The Journal of antimicrobial chemotherapy

Published: August 30, 2021

Cerebrospinal fluid exposure to bictegravir/emtricitabine/tenofovir in HIV-1-infected patients with CNS impairment.

Cerebrospinal fluid exposure to bictegravir/emtricitabine/tenofovir in HIV-1-infected patients with CNS impairment.

Journal: The Journal of antimicrobial chemotherapy

Published: May 06, 2021

Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study.

Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study.

Journal: Drugs in R&D

Published: October 07, 2020

Showing 1-12 of 36

Last Updated: 09/26/2026